Vicarious Surgical (RBOTW) Cash & Equivalents (2020 - 2025)

Vicarious Surgical (RBOTW) has 6 years of Cash & Equivalents data on file, last reported at $2.6 million in Q4 2025.

• Quarterly Cash & Equivalents fell 73.62% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 73.62% YoY) and the FY2025 annual result came in at $2.6 million, down 73.62% from the prior year.
• Cash & Equivalents retreated to $2.6 million in Q4 2025 per RBOTW's latest filing, from $3.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $185.0 million in Q3 2021 and bottomed at $1.0 million in Q1 2021.
• The 5-year median for Cash & Equivalents is $51.4 million (2023), against an average of $66.2 million.
• The widest annual swing landed in 2022, when Cash & Equivalents soared 15173.98%; it then plunged 90.67% in 2024.
• Tracing RBOTW's Cash & Equivalents over 5 years: stood at $173.5 million in 2021, then slumped by 33.02% to $116.2 million in 2022, then tumbled by 54.55% to $52.8 million in 2023, then slumped by 81.57% to $9.7 million in 2024, then slumped by 73.62% to $2.6 million in 2025.
• Per Business Quant, the three latest RBOTW Cash & Equivalents figures stand at $2.6 million (Q4 2025), $3.2 million (Q3 2025), and $24.0 million (Q2 2025).

Peer Comparison